Free Arkansas State Board Test in General and Ocular Therapy and Pharmacology Practice Questions

Sample Practice Questions

Try these 10 sample questions from the Arkansas State Board Test in General and Ocular Therapy and Pharmacology practice bank. Each includes the answer and explanation. Continue with the interactive practice above to review the full question set.

1. 1An Arkansas optometric physician is considering an oral medication for a patient's condition. Which anatomic scope must the condition fall within for the prescription to be within the statutory drug authority?

   1. A. The eye, lids, or adnexa
   2. B. The eye, ear, or nasal cavity
   3. C. The eye, skin, or oral cavity
   4. D. The eye, orbit, or central nervous system

   Answer: A

   Explanation: Arkansas Code § 17-90-101 states that optometry includes "the prescribing and administering of all oral and topical drugs for the diagnosis or treatment only of conditions of the eye, lids, and adnexa." The patient's condition must therefore involve one of those listed structures.

   Reference: Optometry Law 6.20.25 — Arkansas Code § 17-90-101(a)(3)(A), p. 1

2. 2Which Schedule II authority is the specific Arkansas exception to the general prohibition on optometrists possessing, administering, or prescribing Schedule I and II agents?

   1. A. Any stimulant used for visual fatigue
   2. B. Any opioid used after surgery
   3. C. Hydrocodone combination drugs with oral analgesic drugs
   4. D. Methadone used for chronic pain

   Answer: C

   Explanation: Arkansas Code § 17-90-403 excludes Schedules I and II "except hydrocodone combination drugs, regardless of their schedule, in combination with oral analgesic drugs." That is the stated exception.

   Reference: Optometry Law 6.20.25 — Arkansas Code § 17-90-403(b)(1), p. 18

3. 3Before initiating oral-steroid treatment for an eye disorder, what record step does Arkansas require from an optometric physician?

   1. A. A written detailed medical history
   2. B. A new visual-field test only
   3. C. A pharmacy dispensing log
   4. D. A signed surgical consent

   Answer: A

   Explanation: The Board rule states that before initiating treatment with an oral steroid, the optometrist "must take a written detailed medical history including past drug reactions, medical/general health conditions, and current medications." That history must be noted in the record.

   Reference: ASBO Rules — 17 CAR § 380-509

4. 4What foundational emergency-preparedness document must an Arkansas optometric physician establish?

   1. A. A written procedure for emergency situations
   2. B. A pharmacy wholesaler agreement
   3. C. A hospital admitting contract
   4. D. A patient payment protocol

   Answer: A

   Explanation: 17 CAR § 380-505 requires an optometric physician to establish a written procedure for emergency situations.

   Reference: Codeofarrules · Arkansas — 17 CAR § 380-505

5. 5A patient develops an anaphylactic reaction in an Arkansas optometry office. Which medication use is expressly included in the statutory practice of optometry for this emergency?

   1. A. Insulin for hyperglycemia
   2. B. Epinephrine for anaphylaxis
   3. C. Heparin for thrombosis
   4. D. Naloxone for routine pain control

   Answer: B

   Explanation: Arkansas Code § 17-90-101 includes "the prescribing and administering of epinephrine, benadryl, or other comparable medication for the emergency treatment of anaphylaxis or anaphylactic reactions." Epinephrine for this emergency is expressly within scope.

   Reference: Optometry Law 6.20.25 — Arkansas Code § 17-90-101(a)(3)(A), p. 1

6. 6An Arkansas optometric physician writes a permitted hydrocodone-combination prescription. What limit applies under the Optometry Law?

   1. A. A 24-hour supply with one refill
   2. B. A 48-hour supply with no refills
   3. C. A 7-day supply with one refill
   4. D. A 72-hour supply with no refills

   Answer: D

   Explanation: The law states that the prescription "shall not exceed seventy-two (72) hours and shall not authorize refills." Both limits apply to the permitted hydrocodone combination.

   Reference: Optometry Law 6.20.25 — Arkansas Code § 17-90-403(b)(2), pp. 18-19

7. 7An oral-steroid history suggests a contraindication. Which next step satisfies the Arkansas optometry rule before prescribing?

   1. A. Reduce the dose without documentation
   2. B. Consult the patient's family doctor, a physician, or an ophthalmologist and note it in the record
   3. C. Ask the pharmacist to choose an alternative
   4. D. Delay treatment for exactly seven days

   Answer: B

   Explanation: The rule provides that if the history suggests contraindications, "before prescribing a steroid, a consult with the patient’s family doctor, a physician, or an ophthalmologist should be duly noted in the record." The documented consultation is required.

   Reference: ASBO Rules — 17 CAR § 380-509

8. 8Which prior arrangement satisfies the communication element of an Arkansas optometric physician's emergency procedure?

   1. A. An arrangement with an optical laboratory
   2. B. An arrangement with a general physician
   3. C. An arrangement with a lens wholesaler
   4. D. An arrangement with a billing service

   Answer: B

   Explanation: The emergency rule requires a prior arrangement assuring communication with one of four listed resources, including "A general physician." That arrangement satisfies the communication element.

   Reference: Codeofarrules · Arkansas — 17 CAR § 380-505(1)(B)

9. 9An Arkansas optometric physician is credentialed for injection procedures. Which proposed injection remains outside the procedure authority stated in the Optometry Law?

   1. A. Subcutaneous injection
   2. B. Intramuscular injection
   3. C. Intravenous injection
   4. D. Subconjunctival injection

   Answer: C

   Explanation: The statute includes "Injections, excluding intravenous or intraocular injections." An intravenous injection remains excluded even when the optometrist holds the procedure credential.

   Reference: Optometry Law 6.20.25 — Arkansas Code § 17-90-101(a)(3)(D)(i), p. 2

10. 10For an Arkansas Schedule II or III opiate prescription, how does the Board rule cap the total initial administration period at the manufacturer's maximum recommended daily dose?

    1. A. 72 hours
    2. B. 48 hours
    3. C. 5 days
    4. D. 7 days

    Answer: A

    Explanation: 17 CAR § 380-510 limits the total initial administration period at the manufacturer's maximum recommended daily dose to 72 hours.

    Reference: 17 CAR § 380-510(a)(1)(A)(ii)(d) — 17 CAR § 380-510(a)(1)(A)(ii)(b)